CU20080120A7 - DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS - Google Patents

DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS

Info

Publication number
CU20080120A7
CU20080120A7 CU20080120A CU20080120A CU20080120A7 CU 20080120 A7 CU20080120 A7 CU 20080120A7 CU 20080120 A CU20080120 A CU 20080120A CU 20080120 A CU20080120 A CU 20080120A CU 20080120 A7 CU20080120 A7 CU 20080120A7
Authority
CU
Cuba
Prior art keywords
pyrimidinil
aril
urea
derivatives
heteroaryl
Prior art date
Application number
CU20080120A
Other languages
Spanish (es)
Inventor
Vito Guagnano
Pascal Furet
Guido Bold
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority to CU20080120A priority Critical patent/CU20080120A7/en
Publication of CU20080120A7 publication Critical patent/CU20080120A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a heteroaril-aril-ureas de la fórmula (IA), en donde los radicales y símbolos tienen los significados definidos en la presente, al uso de estos compuestos en el tratamiento de enfermedades dependientes de cinasa de proteína, a preparaciones farmacéuticas que comprenden estas heteroaril-aril-ureas, a procesos para la fabricación de estos compuestos novedosos y a métodos de tratamiento que comprenden el uso de estas heteroaril-aril-ureas.The invention relates to heteroaryl-aryl ureas of the formula (IA), wherein the radicals and symbols have the meanings defined herein, to the use of these compounds in the treatment of protein kinase-dependent diseases, to pharmaceutical preparations which comprise these heteroaryl-aryl ureas, to processes for the manufacture of these novel compounds and to methods of treatment comprising the use of these heteroaryl-aryl-ureas.

CU20080120A 2008-06-23 2008-06-23 DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS CU20080120A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20080120A CU20080120A7 (en) 2008-06-23 2008-06-23 DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20080120A CU20080120A7 (en) 2008-06-23 2008-06-23 DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS

Publications (1)

Publication Number Publication Date
CU20080120A7 true CU20080120A7 (en) 2010-08-30

Family

ID=44280864

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20080120A CU20080120A7 (en) 2008-06-23 2008-06-23 DERIVATIVES OF PYRIMIDINIL ARIL UREA AND FGF INHIBITORS

Country Status (1)

Country Link
CU (1) CU20080120A7 (en)

Similar Documents

Publication Publication Date Title
CR10072A (en) PIRIMIDINIL-ARIL-UREA DERIVATIVES THAT ARE FGF INHIBITORS
CY1124928T1 (en) PYRAZOLYL QUINOXALINE KINASE INHIBITORS
CY1120318T1 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients
SV2009003299A (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
CR20110270A (en) Pyryloxy-indoles VEGF-R2 Inhibitors and Use of the Same for the Treatment of Diseases
GT200800242A (en) BICYCLE DERIVATIVES AS CETP INHIBITORS
CO6321282A2 (en) PIPERIDINYLINDOL DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA
UY32859A (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
CL2011000589A1 (en) Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.
EA201290980A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBURONIC ACID
DOP2010000259A (en) UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME-211
ECSP109903A (en) DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
CR20130550A (en) CYCLOPROPILAMINS AS INHIBITORS OF DEMETHYLASE 1 SPECIFIC TO LISINA
EA201100447A1 (en) ORGANIC COMPOUNDS
EA201170772A1 (en) ORGANIC COMPOUNDS
EA201190296A1 (en) DISAHARINOVAYA, DIFUMAROVO-acidic, CI-1-hydroxy-2-naphthoic acid and MONOBENZOYNO-acid salt-4- (dimethylamino) butyl-2- (4 - ((2-AMINO-4-METHYL-6- (pentylamino) pyrimidine -5-IL) METHYL) PHENYL) ACETATE
EA201170832A1 (en) PURINE CONNECTIONS
EA201070327A1 (en) CATECHOLAMINE DERIVATIVES AND THEIR DEVICES
MX2019012847A (en) C5-anilinoquinazoline compounds and their use in treating cancer.
DOP2014000036A (en) PIRIDAZINONE COMPOUNDS AND ITS USE AS DAAO INHIBITORS
ECSP088288A (en) DERIVATIVES OF 7- (2-AMINO-1-HIDROXI-ETIL) -4-HYDROXIBENZOTIAZOL-2 (3H) -ONA AS AGONISTS OF ADRENOCEPTORS ß2
EA201071224A1 (en) LIMK2 INHIBITORS, COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE
UY31860A (en) PIRIDINES OF TIAZOLO AS INHIBITORS OF THE GIRASA DNA
EA201001747A1 (en) BENZOXASINIC DERIVATIVES, ACTING AS AN AGONIST BETA-2-ADRENOCEPTOR, FOR THE TREATMENT OF RESPIRATORY DISORDERS
CL2013003056A1 (en) Compounds derived from (phenyl or pyridin) -ethynyl- (pyridin or pyrimidin) substituted; pharmaceutical composition comprising them; process of preparing this; and its use in the treatment of schizophrenia or cognitive diseases.